ArticleCancer cell international2025
CYP27A1 suppresses brain metastasis via ferroptosis in lung adenocarcinoma: a six-gene signature predicting the immunotherapy response and clinical outcomes.
Article in Cancer cell international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrating Single-Cell, Bulk, and Spatial Transcriptomics Unveils a Novel Ribosome Biogenesis-Related Prognostic Model and DefinesInternational journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundLung adenocarcinoma (LUAD) brain metastasis has limited therapeutic options and a poor prognosis. This study aimed to identify molecular drivers, construct a prognostic model, and assess immunotherapy response.
methodsWe integrated scRNA-seq data from 4 LUAD patients (GSE117570) and bulk RNA-seq data from the TCGA-LUAD cohort. Brain metastasis-associated differentially expressed genes (DEGs) were identified via Seurat. CellChat was used to analyse intercellular communication. A LASSO Cox prognostic model was constructed, and the function of CYP27A1 was validated in vitro.
resultsSix brain metastasis-linked genes (CD9, CYP27A1, HLA-DQB1, PEBP1, PECAM1, and TUBB) formed a risk model. High-risk patients had worse overall survival (HR = 1.91, p < 0.0001) and a reduced immunotherapy response. scRNA-seq revealed that M1 macrophages are involved in metastasis, with CYP27A1 significantly downregulated in LUAD cells. Functionally, CYP27A1 overexpression inhibited proliferation, migration, and invasion by inducing ferroptosis via iron homeostasis and lipid peroxidation (p < 0.05). High-risk patients presented lower immune scores/stromal components. A nomogram integrating the risk score, stage, and EGFR status showed robust 1-3 year predictive accuracy (AUC: 0.749-0.780).
conclusionsCYP27A1 is implicated as a suppressor of LUAD brain metastasis via ferroptosis. The six-gene model facilitates risk stratification, and macrophage-driven microenvironment remodelling informs potential immunotherapy strategies, advancing LUAD precision oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.